RESOURCES & PERSPECTIVES

  1. RTSM/IRT In Clinical Trials: The Complete Guide 1/27/2025

    RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.

  2. Overcoming The Challenges Of Fragmented Supply Chains 1/27/2025

    As trials grow more complex, managing clinical supplies is increasingly challenging. In a recent webinar, experts discussed forecasting, GxP inventory management, and integrated solutions to overcome these hurdles.

  3. Deconstructing Central Rating In Clinical Trials 1/27/2025

    Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this

  4. The Future Of Clinical Trials: 2025 Outlook 1/27/2025

    Looking ahead to 2025, clinical trials will evolve with new technologies, regulatory shifts, and emerging therapies. Explore key trends shaping the future of the industry.

  5. Electronic Hauser Diary For Parkinson's Clinical Trials 12/9/2024

    In honor of World Movement Disorders Day, we highlight advances in Parkinson’s disease care. At the 2024 MDS Congress, Signant presented research on electronic diaries for tracking PD patients' functional status.

  6. How To Differentiate With A Unified eClinical Solution 12/9/2024

    Clinical trials are increasingly complex for sites, sponsors, and CROs. In a recent webinar, experts Bill Byrom and Jan Breemans shared how a unified eClinical platform simplifies operations and enhances data quality.

  7. Deconstructing Central Rating In Clinical Trials 12/9/2024

    What is Central Rating and how can it be used to improve data quality and success rates in clinical trials?

  8. How eCOA Improves Data Quality In Clinical Trials 11/20/2024

    eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.

  9. Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology 11/20/2024

    Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.

  10. Antibody-Drug Conjugates In Oncology: Revolutionizing Cancer Treatment 11/20/2024

    ADCs are reshaping cancer treatment by combining targeted delivery with potent cell-killing agents. Learn how these therapies offer new hope for patients and exciting opportunities for drug developers.